WHO Collaborating Centres
Global database
Version 1.5
Search / List / Details
Ref.No. [Initiator]
AUT-14 [Headquarters]
Status
Active
Title of the centre:
  WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies

Director / Head: 
  Dr Sabine Vogler
  Ms Claudia Habl




Institution:
  Health Economics Department
  Gesundheit Österreich GmbH (GÖG) (Austrian Health Institute)
Address:
  Stubenring 6
  1010
  Vienna
Town:
  Vienna
Country:
  AUSTRIA
Region:
  EURO
Phone:
  +43 1 515 61-147
Fax:
  +43 1 513 84 72
Web Site:
  http://whocc.goeg.at/
Date of Designation:
  16/Jul/2010
Last Redesignation:
  16/Jul/2010
Expiry:
  16/Jul/2014
Terms of Reference:
  1. To provide scientific advice and technical assistance to WHO and its Member States / regions on performing and interpreting price surveys and comparisons; on understanding, collecting and analyzing pharmaceutical pricing and reimbursement information and on the development of national reporting systems 
  2. To further develop and refine the methodological framework for indicators to measure, compare and benchmark pharmaceutical policies, in coordination with the WHO database development process 
  3. To assist in the organization of meetings of WHO Member States / regions in the field of pharmaceutical pricing and reimbursement allowing for an exchange of information and experiences, to disseminate information on pharmaceutical policies (via websites, studies and network meetings) and to work on a the development and promotion of a common understanding and language on pharmaceutical issues 
  4.  
  5.  
  6.  
  7.  
  8.  
  9.  
  10.  
Subjects:
  1. Pharmaceuticals (including essential drugs and medicines) 
  2. Health systems research & development 
  3.  
Types of activity:
  1. Collection; collation and dissemination of information 
  2. Information dissemination 
  3. Coordination of activities carried out by several institutions (e.g. other WHO collaborating centres) 
WHO Outputs:
  Ower: 11.1 - Formulation and monitoring of comprehensive national policies on access, quality and use of essential medical products and technologies advocated and supported.
  Ower: 11.3 - Evidence based policy guidance on promoting scientifically sound and cost-effective use of medical products and technologies by health workers and consumers developed and supported within the Secretariat and regional and national programmes.
 
Responsible Officer:
  FORTE Gilles Bernard
Phone:
  13617/14652
Email:
  forteg@who.int

Technical Counterpart:
  PEDERSEN Hanne Bak
Phone:
  +45 45 33 66 98
Email:
  pedersenh@who.int
Access to annual progress reports and the current workplan (this is accessible to WHO Staff Members only):
  Link to eWork